NCT07518329 2026-04-08
Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.
Arovella Therapeutics Ltd
Phase 1 Not yet recruiting
Arovella Therapeutics Ltd
St. Justine's Hospital
Children's Hospital of Philadelphia
Dana-Farber Cancer Institute
Nantes University Hospital
Baylor College of Medicine
Anhui Provincial Hospital
Guangzhou Bio-gene Technology Co., Ltd
University College, London